GSK to Acquire Nuvalent in $10.6B Lung Cancer Expansion
LONDON, United Kingdom & BOSTON, Massachusetts, USA – June 8, 2026 GSK has announced a definitive agreement to acquire...
Hematology
Advertisement
Incyte to Acquire Vega Therapeutics for $2 Billion Deal
WILMINGTON, Delaware, USA – June 8, 2026 Incyte Corporation has announced a definitive agreement to acquire Vega Therapeutics, a...
Roche Partners with Nurix to Advance BTK Degrader Bexobrutideg Across Cancer, Immunology and Neurology
BASEL, Switzerland, June 8, 2026 Roche announced a global licensing and collaboration agreement with Nurix Therapeutics to co-develop and...
Sanofi Wins EU Approval for Sarclisa SC in Multiple Myeloma
PARIS, France, June 8, 2026 Sanofi announced that the European Commission has approved Sarclisa® (isatuximab) subcutaneous (SC) for the...
Fulcrum Ends Pociredir Program After FDA Concerns Over Sickle Cell Therapy
CAMBRIDGE, Mass., June 1, 2026 Fulcrum Therapeutics announced the discontinuation of its lead investigational therapy pociredir for the treatment...
Advertisements
Karyopharm Highlights Phase 3 SENTRY Trial Progress in Myelofibrosis
NEWTON, Mass., June 1, 2026 Karyopharm Therapeutics has announced that it will host an investor conference call featuring leading...
UCB and Biogen Report Positive Phase 3 Lupus Results for Dapirolizumab Pegol in The Lancet
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 1, 2026 UCB and Biogen announced the publication of full Phase 3 PHOENYCS...
Agios Expands Rare Hematology Portfolio with Global Cevidoplenib Licensing Deal
CAMBRIDGE, Mass., June 1, 2026 Agios Pharmaceuticals has entered an exclusive global licensing agreement with South Korea-based Oscotec to...
BioInvent to Showcase BI-1206 and BI-1808 Hematology Progress at June KOL Event
LUND, Sweden, June 1, 2026 BioInvent International AB announced that it will host a key opinion leader (KOL) event...
PeproMene Bio CAR-T Therapy Shows Durable Lymphoma Responses
IRVINE, California, May 29, 2026 PeproMene Bio, Inc. has announced that updated clinical data from its ongoing Phase 1...
Advertisement
